CompanyDrug

BeiGene’s Brukinsa Outperforms Acalabrutinib in MAIC for Relapsed/Refractory CLL, Says BeiGene

CompanyDrug

Merck’s Mavenclad Demonstrates Lasting Efficacy in RMS Patients, New Data Show

Legal / IP

AlzeCure Pharma’s Alzheimer’s Drug Candidate ACD856 Receives Global Patent Awards

CompanyDeals

Sino-Biocan Secures Series B Funding to Boost Cell and Gene Therapy Production Platforms

CompanyDrug

AIM Vaccine Advances Pneumococcal Vaccine and Initiates Phase II Meningococcal Study

CompanyDeals

ArkBio Partners with SDODT to Boost ADHD Treatment Marketing and Commercialization

CompanyDrug

Hainan Poly Pharm Secures Tentative FDA Approval for Generic Version of UCB’s Briviact

CompanyDrug

BMS’s Yervoy-Opdivo Combo on Track for Breakthrough Therapy Designation in China for CRC

CompanyDeals

Beijing Tinavi Medical Technologies to Form Radiotherapy Equipment JV with IM INNO and Celestial Oncology

CompanyDrug

Pfizer’s RSV Vaccine Demonstrates Durable Efficacy with Abrysvo Phase III Results

Policy / Regulatory

Biden’s Executive Order May Restrict Data Access for China-Based Life Science Firms in the US

CompanyDrug

Shanghai Fosun Pharma’s GCK-01 CAR-NK Cell Therapy Gets Tacit Clinical Approval from China’s CDE